3. Results
blindness
BLINDNESS, UTI
A total of 267 patients were evaluated between January 2019 and December 2021, and 239 of these were initially enrolled in the study to form the intention-to-treat population, which was given UTI (n = 120) or placebo (n = 119) treatment in a random manner. There were no cases of open blindness observed throughout the research period. Furthermore, no statistically significant differences were discovered in terms of the baseline data between the 2 subgroups (Table Comparison of baseline data.BMI = body mass index, ISS = injury severity score, SD = standard deviation, UTI = ulinastatin.Trial profile.